Immunic, Inc. (IMUX) stock
IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.52−0.27 (-3.47%)
Close on Nov 13, 2026Market cap $102.61MP/E –Yield 0.00%
Immunic enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Immunic's enterprise value was -$44.30M on Nov 11, 2026, against $35.10M a year earlier. Over the last 5 years it ranged from -$52.63M to $219.94M, with a median of $21.52M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$44.30M | -352.9% |
| 2025 | Dec 31, 2025 | $17.52M | -43.5% |
| 2024 | Dec 31, 2024 | $31.01M | +330.4% |
| 2023 | Dec 29, 2023 | $7.20M | – |
| 2022 | Dec 30, 2022 | -$29.98M | -121.3% |
| 2021 | Dec 31, 2021 | $140.76M | -23.3% |
| 2020 | Dec 31, 2020 | $183.60M | +173.1% |
| 2019 | Dec 31, 2019 | $67.23M | – |
| 2018 | Dec 31, 2018 | -$3.71M | -102.8% |
| 2017 | Dec 29, 2017 | $134.52M | +212.1% |
| 2016 | Dec 30, 2016 | $43.09M | -73.5% |
| 2015 | Dec 31, 2015 | $162.77M | -54.2% |
| 2014 | Dec 31, 2014 | $355.51M | – |
See a number that looks wrong?